Johns Hopkins School of Medicine is one of more than 50 clinical trial sites across the country testing potential therapies for COVID-19 outpatients with mild to moderate symptoms.
Johns Hopkins School of Medicine is one of more than 50 clinical trial sites across the country testing potential therapies for COVID-19 outpatients with mild to moderate symptoms.